Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CNS CoTSE:4076 -0.40%84 EBITDA Margin % is 9.22% as of Feb. 2026, which is 11% below its 10-year median of 10.37. GuruFocus rates TSE:4076 with a GF Score™ of 84/100 and a GF Value™ of 円1,869.66 (Fairly Valued). The stock has 4 warning signs investors should review. Among 2,826 Software companies, CNS Co ranks better than 57.89% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. CNS Co's EBITDA for the
three
months ended in Feb. 2026 was 円181 Mil. CNS Co's Revenue for the
three
months ended in Feb. 2026 was 円1,965 Mil. Therefore, CNS Co's EBITDA margin for the quarter that ended in Feb. 2026 was 9.22%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
CNS Co EBITDA Margin % Related Terms
CNS Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for CNS Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4076 vs IBM, ACN, FISV: EBITDA Margin % Comparison
For the Information Technology Services subindustry, CNS Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CNS Co EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, CNS Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where CNS Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CNS Co (TSE:4076) has a EBITDA Margin % of 9.22% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CNS Co and its competitors. This is 11% below median its historical median of 10.37. Over the past decade, CNS Co's EBITDA Margin % has ranged from 5.05 to 11.45. According to the industry distribution chart, CNS Co ranks #1190 out of 2826 companies in the Software industry, placing it in the top 42.1%.
Is CNS Co's EBITDA Margin % too high?
CNS Co's current EBITDA Margin % of 9.22% is 11% below median its 10-year median of 10.37. Over the past 10 years, this metric has ranged from a low of 5.05 to a high of 11.45. The Software industry median EBITDA Margin % is 8.17. CNS Co's value of 9.22% is 12.9% above this industry median. Based on the distribution chart, CNS Co ranks #1190 out of 2826 companies in the Software industry, which is above the industry midpoint. Overall, CNS Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CNS Co's EBITDA Margin % compare to IBM and ACN?
According to the Software industry distribution chart, CNS Co ranks #1190 out of 2826 companies for EBITDA Margin %. This puts CNS Co in the upper half of its industry. The industry median EBITDA Margin % is 8.17. CNS Co's value of 9.22% is 12.9% above this benchmark. Historically, CNS Co's own EBITDA Margin % has ranged from 5.05 to 11.45 over the past decade. While the company's 10-year median is 10.37 vs. the industry median of 8.17, CNS Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.17, based on 2,826 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CNS Co's current EBITDA Margin % of 9.22% is 12.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CNS Co and its competitors. For the Software industry, the median EBITDA Margin % is 8.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CNS Co's current EBITDA Margin % is 9.22%, which is 11% below median its own 10-year median of 10.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNS Co stock overvalued right now?
Based on GuruFocus' analysis, CNS Co (TSE:4076) is currently considered Fairly Valued. The stock's GF Value™ is 円1,869.66, compared to a current price of 円1,980.00 — trading 5.9% above its estimated fair value. The current EBITDA Margin % is 9.22%, which is 11% below median its 10-year median of 10.37 and 12.9% above the Software industry median of 8.17. CNS Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For CNS Co (TSE:4076), the current EBITDA Margin % is 9.22% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CNS Co (TSE:4076) Overvalued in 2026?
Based on GuruFocus' analysis, CNS Co stock appears to be overvalued.
The current stock price of 円1,980.00 is trading 5.9% above its estimated GF Value™ of 円1,869.66.
GuruFocus considers CNS Co to be Fairly Valued.
Key valuation signals for TSE:4076:
EBITDA Margin %: 9.22% (11% below median its 10-year median of 10.37)
GF Value™: 円1,869.66 vs. price of 円1,980.00 (5.9% above fair value)
Industry Position: 12.9% above the Software median (#1190 of 2826)
No single metric tells the full story. See the TSE:4076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CNS Co Ltd is an information technology solutions company engaged in providing system engineering services. The company offers various solutions to its clients such as consulting services related to digital transformation, data analysis solutions, business system integration, and the implementation, construction, and operation of optimal system infrastructure.
84GF Score
Get the complete analysis for TSE:4076
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4076 has been successfully added to your 
